Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Dr. Reddy's Laboratories Limited
  6. News
  7. Summary
    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
End-of-day quote. End-of-day quote Bombay Stock Exchange - 06/11
5451.2 INR   +3.03%
06/11Asian ADRs Move Lower in Friday Trading
MT
06/10Asian ADRs Move Higher in Thursday Trading
MT
06/09DR REDDY LABORATORIESá : Partners with Rockwell Industries for COVID-19 Vaccine Storage
MT
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sensex, Nifty end lower as banks drop; pharma shines

09/18/2020 | 06:58am EDT
People walk past the Bombay Stock Exchange building in Mumbai

Indian shares gave up early gains to end lower on Friday as banking stocks fell in afternoon trading, with HDFC Bank closing at a month's low, although a jump in pharma stocks capped losses on the Nifty.

The blue-chip NSE Nifty 50 index closed 0.1% lower at 11,504.95, while the benchmark S&P BSE Sensex, which has fewer pharma components, ended down 0.34% at 38,845.82.

The Nifty ended the week 0.4% higher, while the Sensex closed a tad lower.

The Nifty Bank Index finished 1.3% lower at its worst closing level in a month, capping its third straight week of losses, dragged by a 2.4% slide in top private-sector lender HDFC Bank.

The Nifty Pharma index clocked its best day since Aug. 10, closing up 5%, as drugmaker Dr.Reddy's Laboratories Ltd added 10.5% to close at a record high.

The pharmaceutical firm settled a patent litigation with U.S. drugmaker Bristol-Myers Squibb Co over the cancer treatment Revlimid, prompting analyst upgrades to its stock.

Drugmakers Lupin Ltd and Cipla Ltd jumped 4.7% and 7.3%, respectively, after U.S.-listed Perrigo Company Plc issued a U.S. nationwide recall of its albuterol sulfate inhalation aerosol product due to complaints of clogging issues.

Cipla and Lupin have their own versions of the aerosol product approved by the U.S. FDA.

Investor sentiment in broader markets was also tepid on worries over a resurgence in coronavirus cases and disappointment that central banks merely affirmed their monetary support this week, without promising new stimulus.

(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Ramakrishnan M.)


ę Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
DR. REDDY'S LABORATORIES LIMITED 3.03% 5451.2 End-of-day quote.4.75%
NIFTY 50 0.39% 15799.35 Delayed Quote.13.00%
NIFTY BANK -0.24% 35047.4 Delayed Quote.12.10%
PERRIGO COMPANY PLC -2.33% 47.73 Delayed Quote.6.73%
SENSEX 30 0.33% 52474.76 Real-time Quote.9.89%
All news about DR. REDDY'S LABORATORIES LIMITED
06/11Asian ADRs Move Lower in Friday Trading
MT
06/10Asian ADRs Move Higher in Thursday Trading
MT
06/09DR REDDY LABORATORIESá : Partners with Rockwell Industries for COVID-19 Vaccine ..
MT
06/07DR REDDY LABORATORIESá : . Reddy's Recalls Atorvastatin Calcium Bottles in US ov..
MT
06/04SUB : Allotment of Equity Shares on exercise of ESOP (Form 6-K)
PU
06/03Snowman Logistics Partners with Dr. Reddy's Laboratories for Delivery of COVI..
MT
06/02Asian ADRs Slightly Lower in Wednesday Trading
MT
06/01Asian ADRs Climb Higher in Tuesday Trading
MT
05/26Asian ADRs Move Higher Wednesday Amid Gains by Techs
MT
05/26DR REDDY LABORATORIESá : Delhi High Court Dismisses An Injunction Application Fi..
AQ
More news
Financials
Sales 2021 191 B 2 608 M 2 608 M
Net income 2021 22 584 M 308 M 308 M
Net cash 2021 10 733 M 147 M 147 M
P/E ratio 2021 38,1x
Yield 2021 0,45%
Capitalization 904 B 12 340 M 12 338 M
EV / Sales 2021 4,68x
EV / Sales 2022 3,78x
Nbr of Employees 21 650
Free-Float 66,7%
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 33
Average target price 5 670,06 INR
Last Close Price 5 451,20 INR
Spread / Highest target 17,4%
Spread / Average Target 4,01%
Spread / Lowest Target -21,1%
EPS Revisions
Managers and Directors
NameTitle
Erez Israeli Chief Executive & Operating Officer
Parag Agarwal Chief Financial Officer
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Sandeep Poddar Secretary & Compliance Officer
Sector and Competitors
1st jan.Capitalization (M$)
DR. REDDY'S LABORATORIES LIMITED4.75%12 340
JOHNSON & JOHNSON4.82%434 405
ROCHE HOLDING AG10.68%328 612
PFIZER, INC.9.07%224 747
NOVARTIS AG-0.39%208 035
ABBVIE INC.7.72%203 857